Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL417799 (Pseudochelerythrine, Sangrovit, Sanguinarin, Sanguinarine) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
acetylcholinesterase (Yt blood group)/Acetylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL220] [GtoPdb: 2465] [UniProtKB: P22303] | ||||||||
ChEMBL | Inhibition of AChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method | B | 5.91 | pIC50 | 1220 | nM | IC50 | Eur J Med Chem (2020) 200: 112415-112415 [PMID:32454229] |
Bcl2-antagonist of cell death (BAD) in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3817] [UniProtKB: Q92934] | ||||||||
ChEMBL | Displacement of fluorescein-labeled Bak-BH3 peptide from human Bcl-XL by fluorescence polarization assay | B | 4.72 | pIC50 | 19000 | nM | IC50 | J Med Chem (2008) 51: 6699-6710 [PMID:18925736] |
butyrylcholinesterase/Butyrylcholinesterase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1914] [GtoPdb: 2471] [UniProtKB: P06276] | ||||||||
ChEMBL | Inhibition of BuChE (unknown origin) preincubated for 30 mins followed by substrate addition acetylthiocholineiodide measured after 40 mins by Ellman's method | B | 5.15 | pIC50 | 7080 | nM | IC50 | Eur J Med Chem (2020) 200: 112415-112415 [PMID:32454229] |
Cell division protein ftsZ in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3999] [UniProtKB: P0A9A6] | ||||||||
ChEMBL | Inhibition of Escherichia coli recombinant FTsZ incubated for 10 mins in presence of GTP by spectrofluorimeter analysis | B | 5.52 | pIC50 | 3000 | nM | IC50 | Eur J Med Chem (2020) 190: 112132-112132 [PMID:32066012] |
nuclear factor kappa B subunit 1/nuclear factor kappa B subunit 2/RELA proto-oncogene, NF-kB subunit/Nuclear factor NF-kappa-B complex in Human (target type: PROTEIN COMPLEX GROUP) [ChEMBL: CHEMBL2094258] [GtoPdb: 3281, 3282, 3280] [UniProtKB: P19838, Q00653, Q04206] | ||||||||
ChEMBL | Inhibition of NF-kappaB transactivation in TNF-alpha-stimulated human K562 cells preincubated for 2 hrs followed by TNF-alpha challenge measured after 6 hrs by dual luciferase reporter gene assay | B | 5.7 | pIC50 | 2000 | nM | IC50 | Bioorg Med Chem (2014) 22: 3008-3015 [PMID:24775915] |
regulator of G-protein signaling 17/Regulator of G-protein signaling 17 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295974] [GtoPdb: 2801] [UniProtKB: Q9UGC6] | ||||||||
ChEMBL | Binding affinity to RGS17 (unknown origin) by ITC method | B | 6 | pKd | 1000 | nM | Kd | J Nat Prod (2017) 80: 1992-2000 [PMID:28621943] |
ChEMBL | Inhibition of RGS17 (unknown origin) C117A mutant interaction with biotinylated Galphao after 30 mins in presence of AMF and GDP by AlphaScreen assay | B | 4 | pIC50 | >100000 | nM | IC50 | J Nat Prod (2017) 80: 1992-2000 [PMID:28621943] |
ChEMBL | Inhibition of wild type GST-tagged RGS17 (unknown origin) interaction with biotinylated Galphao after 30 mins in presence of AMF and GDP by AlphaScreen assay | B | 4.14 | pIC50 | 72800 | nM | IC50 | J Nat Prod (2017) 80: 1992-2000 [PMID:28621943] |
GtoPdb | - | - | 4.14 | pIC50 | 72800 | nM | IC50 | J Nat Prod (2017) 80: 1992-2000 [PMID:28621943] |
ChEMBL | Inhibition of RGS17 (unknown origin) GAP activity in presence of GTP by malachite green dye based assay | B | 4.92 | pIC50 | 12000 | nM | IC50 | J Nat Prod (2017) 80: 1992-2000 [PMID:28621943] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]